Ignite Creation Date:
2025-12-25 @ 12:10 AM
Ignite Modification Date:
2025-12-28 @ 3:42 AM
Study NCT ID:
NCT07045558
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-07-01
First Post:
2025-06-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
HAIC + Atezolizumab Plus Bevacizumab in Unresectable HCC
Sponsor:
RenJi Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
LY2025-039-C
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None